Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques

Nephrology

Volumn 11, Issue 3, 2006, Pages 261-266

  Yehia, Maha ^a   Matheson, Philip J ^a,c   Merrilees, Mervyn J ^b   Beaumont, Brent W ^b   Pilmore, Helen L ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Alpha smooth muscle actin; Chronic allograft nephropathy; Macrophage; Protocol biopsy; T cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CD45RA ANTIGEN; CHLORDANE; CREATININE; HYALIN; MONOCLONAL ANTIBODY;

ADULT; ARTERIOLE; ARTICLE; CELL COUNT; CELL INFILTRATION; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GRAFT RECIPIENT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; INCIDENCE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY GRAFT; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MEMORY T LYMPHOCYTE; PATHOGENESIS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; BIOPSY; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHROSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33744796811     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00561.x     Document Type: Article

References (18)

1. Peeters J, Roels L, Vanrentherghem Y. Chronic renal allograft failure: Clinical overview. Kidney Int. 1995 48 Suppl. 52 S97 101.
2. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999 55 : 713 23.
3. Serón D, Moreso F, Bover J et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int. 1997 51 : 310 16.
4. Yilmaz S, Tomlanovich S, Mathew T et al. Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end point for long-term graft survival in multicentre studies. J. Am. Soc. Nephrol. 2003 14 : 773 9.
5. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson C. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int. 2002 62 : 311 18.
6. Regele H, Böhmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J. Am. Soc. Nephrol. 2002 13 : 2372 80.
7. Ibrahim S, Dawson DV, Sanfilipo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45Ro. Transplantation 1995 59 : 724 8.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999 130 : 461 70.
9. Mihatsch MJ, Morozumi K, Strom EH, Ryffel B, Gudat F, Thiel G. Renal transplant morphology after long term therapy with cyclosporine. Transplant. Proc. 1995 27 : 39 42.
10. Nankivell BJ, Borrows RJ, Fung CL-S, O'Connell P, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003 349 : 2326 33.
11. Isoneimi H, Nurmeinen M, Tikanen M et al. Risk factors predicting chronic rejection of renal allografts. Transplantation 1994 57 : 68 72.
12. Isoneimi H, Kyllonen L, Eklund B et al. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Transplant. Proc. 1995 27 : 875 7.
13. Marcen R, Orofino L, Pascual J et al. Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 1998 66 : 461 6.
14. Ozdemir BH, Ozdemir FN, Gungen Y, Haberal M. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am. J. Kidney Dis. 2002 39 : 347 53.
15. Pilmore HL, Eris JM, Painter DM, Bishop GA, McCaughan GW. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 1999 67 : 929 33.
16. Pedagogos E, Hewitson TD, Walker RG, Nicholis KM, Becker GJ. Myofibroblast involvement in chronic transplant rejection. Transplantation 1997 64 : 1192 7.
17. Viklicky O, Matl I, Bohmova R et al. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy. Physiol. Res. 2003 52 : 353 60.
18. Grimm P, Mckenna R, Nickerson P et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J. Am. Soc. Nephrol. 1999 10 : 1582 9.